LU90004I2 - Levovist - Google Patents
LevovistInfo
- Publication number
- LU90004I2 LU90004I2 LU90004C LU90004C LU90004I2 LU 90004 I2 LU90004 I2 LU 90004I2 LU 90004 C LU90004 C LU 90004C LU 90004 C LU90004 C LU 90004C LU 90004 I2 LU90004 I2 LU 90004I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- microparticles
- levovist
- myocardium
- spleen
- organs
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 abstract 2
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Acoustics & Sound (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Fats And Perfumes (AREA)
- Junction Field-Effect Transistors (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Gyroscopes (AREA)
- Air Conditioning Control Device (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Contrast agents for ultrasonic diagnosis consisting of gas bubbles and microparticles are described and are characterised in that they contain as microparticles a mixture of at least one (C10-C20)-fatty acid with at least one solid which has no interfacial activity, suspended in a liquid vehicle. They provide contrast in ultrasonic imaging of the right and left heart, the myocardium and other organs such as the liver, spleen and kidney, after intravenous administration.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3834705A DE3834705A1 (en) | 1988-10-07 | 1988-10-07 | ULTRASONIC CONTRASTING AGENTS FROM GAS BUBBLES AND MICROPARTICLES CONTAINING FATTY ACID |
Publications (1)
Publication Number | Publication Date |
---|---|
LU90004I2 true LU90004I2 (en) | 1997-03-04 |
Family
ID=6364930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU90004C LU90004I2 (en) | 1988-10-07 | 1997-01-08 | Levovist |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0365467B1 (en) |
JP (1) | JPH0737394B2 (en) |
KR (1) | KR970001433B1 (en) |
CN (1) | CN1027575C (en) |
AT (1) | ATE93145T1 (en) |
AU (1) | AU627456B2 (en) |
CA (1) | CA1338507C (en) |
DE (2) | DE3834705A1 (en) |
DK (1) | DK99789A (en) |
ES (1) | ES2059814T3 (en) |
FI (1) | FI100170B (en) |
IE (1) | IE65243B1 (en) |
IL (1) | IL90028A (en) |
LU (1) | LU90004I2 (en) |
NL (1) | NL970009I2 (en) |
NO (2) | NO178139C (en) |
NZ (1) | NZ228781A (en) |
PT (1) | PT91523B (en) |
ZA (1) | ZA892885B (en) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607661A (en) * | 1991-07-05 | 1997-03-04 | Nycomed Imaging As | Aggregates of x-ray microparticles for ultrasound imaging |
MX9205298A (en) | 1991-09-17 | 1993-05-01 | Steven Carl Quay | GASEOUS ULTRASOUND CONTRASTING MEDIA AND METHOD FOR SELECTING GASES TO BE USED AS ULTRASOUND CONTRASTING MEDIA |
US6723303B1 (en) | 1991-09-17 | 2004-04-20 | Amersham Health, As | Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane |
CA2119129C (en) * | 1991-09-17 | 1999-11-09 | Steven C. Quay | Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
US5409688A (en) * | 1991-09-17 | 1995-04-25 | Sonus Pharmaceuticals, Inc. | Gaseous ultrasound contrast media |
US5196183A (en) * | 1991-12-04 | 1993-03-23 | Sterling Winthrop Inc. | Contrast agents for ultrasound imaging |
GB9200388D0 (en) * | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
GB9200387D0 (en) * | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
NZ262237A (en) * | 1993-01-25 | 1997-06-24 | Sonus Pharma Inc | Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in |
US5558855A (en) * | 1993-01-25 | 1996-09-24 | Sonus Pharmaceuticals | Phase shift colloids as ultrasound contrast agents |
IL108416A (en) | 1993-01-25 | 1998-10-30 | Sonus Pharma Inc | Phase shift colloids as ultrasound contrast agents |
GB9402867D0 (en) * | 1994-02-15 | 1994-04-06 | Nycomed Imaging As | Improvements in or relating to contrast agents |
DE4406474A1 (en) * | 1994-02-23 | 1995-08-24 | Schering Ag | Gas-containing microparticles, agents containing them, their use in ultrasound diagnostics, and methods for producing the particles and agents |
EP0699445A3 (en) * | 1994-08-04 | 1996-04-17 | Gakko Houjin Toin Gakuen | Method for the production of microbubble-type ultrasonic contrast agent by surfactant |
DE19602930A1 (en) * | 1996-01-18 | 1997-07-24 | Schering Ag | Porous matrices made of low molecular weight substances for the generation of stable gas bubble suspensions, their use as ultrasound contrast agents and processes for their production |
GB9808582D0 (en) * | 1998-04-22 | 1998-06-24 | Nycomed Imaging As | Improvements in or relating to contrast agents |
AU1705300A (en) | 1998-10-12 | 2000-05-01 | Mallinckrodt, Inc. | Novel ultrasound contrast agents |
DE19950311A1 (en) * | 1999-10-13 | 2001-04-19 | Schering Ag | Stable storage of parenteral ultrasonic contrast agent formulation, using vial closed with dry stopper to prevent reduction of in vivo effectiveness |
DE19952738A1 (en) * | 1999-10-27 | 2001-05-23 | Schering Ag | Improved suspensions of ultrasound contrast media |
US7109167B2 (en) | 2000-06-02 | 2006-09-19 | Bracco International B.V. | Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
JP3819845B2 (en) | 2001-04-06 | 2006-09-13 | ブラッコ・リサーチ・ソシエテ・アノニム | Improved method for measuring local physical parameters in fluid filled cavities |
WO2003074005A2 (en) | 2002-03-01 | 2003-09-12 | Dyax Corp. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
WO2004065621A1 (en) | 2002-03-01 | 2004-08-05 | Dyax Corp. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
US7462366B2 (en) | 2002-03-29 | 2008-12-09 | Boston Scientific Scimed, Inc. | Drug delivery particle |
US7842377B2 (en) | 2003-08-08 | 2010-11-30 | Boston Scientific Scimed, Inc. | Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
US8012454B2 (en) | 2002-08-30 | 2011-09-06 | Boston Scientific Scimed, Inc. | Embolization |
US7883490B2 (en) | 2002-10-23 | 2011-02-08 | Boston Scientific Scimed, Inc. | Mixing and delivery of therapeutic compositions |
EP1603935A4 (en) | 2003-03-03 | 2007-03-21 | Dyax Corp | PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF |
US7976823B2 (en) | 2003-08-29 | 2011-07-12 | Boston Scientific Scimed, Inc. | Ferromagnetic particles and methods |
US7901770B2 (en) | 2003-11-04 | 2011-03-08 | Boston Scientific Scimed, Inc. | Embolic compositions |
KR101001547B1 (en) | 2004-01-28 | 2010-12-17 | 삼성에스디아이 주식회사 | A fabric solar cell and a method for preparing the same |
US7736671B2 (en) | 2004-03-02 | 2010-06-15 | Boston Scientific Scimed, Inc. | Embolization |
US8173176B2 (en) | 2004-03-30 | 2012-05-08 | Boston Scientific Scimed, Inc. | Embolization |
US7311861B2 (en) | 2004-06-01 | 2007-12-25 | Boston Scientific Scimed, Inc. | Embolization |
US8012457B2 (en) | 2004-06-04 | 2011-09-06 | Acusphere, Inc. | Ultrasound contrast agent dosage formulation |
US8425550B2 (en) | 2004-12-01 | 2013-04-23 | Boston Scientific Scimed, Inc. | Embolic coils |
US7858183B2 (en) | 2005-03-02 | 2010-12-28 | Boston Scientific Scimed, Inc. | Particles |
US7727555B2 (en) | 2005-03-02 | 2010-06-01 | Boston Scientific Scimed, Inc. | Particles |
US7963287B2 (en) | 2005-04-28 | 2011-06-21 | Boston Scientific Scimed, Inc. | Tissue-treatment methods |
US9463426B2 (en) | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
US8007509B2 (en) | 2005-10-12 | 2011-08-30 | Boston Scientific Scimed, Inc. | Coil assemblies, components and methods |
US8101197B2 (en) | 2005-12-19 | 2012-01-24 | Stryker Corporation | Forming coils |
US8152839B2 (en) | 2005-12-19 | 2012-04-10 | Boston Scientific Scimed, Inc. | Embolic coils |
US7947368B2 (en) | 2005-12-21 | 2011-05-24 | Boston Scientific Scimed, Inc. | Block copolymer particles |
US8414927B2 (en) | 2006-11-03 | 2013-04-09 | Boston Scientific Scimed, Inc. | Cross-linked polymer particles |
JP5196896B2 (en) * | 2007-07-13 | 2013-05-15 | 花王株式会社 | Method for producing fine bubble precursor |
WO2021141595A1 (en) * | 2020-01-10 | 2021-07-15 | Advanced Microbubbles Laboratories Llc | Preparation and preservation of collagen microbubbles |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3640271A (en) | 1969-06-30 | 1972-02-08 | Ibm | Blood flow pressure measurement technique employing injected bubbled and ultrasonic frequency scanning |
US4276885A (en) | 1979-05-04 | 1981-07-07 | Rasor Associates, Inc | Ultrasonic image enhancement |
US4265251A (en) | 1979-06-28 | 1981-05-05 | Rasor Associates, Inc. | Method of determining pressure within liquid containing vessel |
DE3173476D1 (en) | 1980-11-17 | 1986-02-20 | Schering Ag | Composition generating microbubbles |
DE3141641A1 (en) | 1981-10-16 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION |
JPS5920532A (en) * | 1982-07-23 | 1984-02-02 | Nippon Denso Co Ltd | Method of controlling quantity of fuel for internal combustion engine on vehicle |
DE3313946A1 (en) * | 1983-04-15 | 1984-10-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS |
DE3313947A1 (en) * | 1983-04-15 | 1984-10-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS |
DE3637926C1 (en) * | 1986-11-05 | 1987-11-26 | Schering Ag | Ultrasonic manometry in a liquid using microbubbles |
-
1988
- 1988-10-07 DE DE3834705A patent/DE3834705A1/en not_active Withdrawn
-
1989
- 1989-02-13 NO NO890609A patent/NO178139C/en not_active IP Right Cessation
- 1989-02-16 FI FI890749A patent/FI100170B/en not_active IP Right Cessation
- 1989-03-01 DK DK099789A patent/DK99789A/en not_active Application Discontinuation
- 1989-03-11 KR KR1019890002989A patent/KR970001433B1/en not_active IP Right Cessation
- 1989-04-06 ES ES89730095T patent/ES2059814T3/en not_active Expired - Lifetime
- 1989-04-06 AT AT89730095T patent/ATE93145T1/en active
- 1989-04-06 DE DE8989730095T patent/DE58905318D1/en not_active Expired - Fee Related
- 1989-04-06 EP EP89730095A patent/EP0365467B1/en not_active Expired - Lifetime
- 1989-04-11 IE IE114989A patent/IE65243B1/en not_active IP Right Cessation
- 1989-04-18 NZ NZ228781A patent/NZ228781A/en unknown
- 1989-04-19 IL IL90028A patent/IL90028A/en not_active IP Right Cessation
- 1989-04-19 ZA ZA892885A patent/ZA892885B/en unknown
- 1989-04-21 CA CA000597471A patent/CA1338507C/en not_active Expired - Fee Related
- 1989-05-01 AU AU33900/89A patent/AU627456B2/en not_active Ceased
- 1989-08-23 PT PT91523A patent/PT91523B/en not_active IP Right Cessation
- 1989-10-04 JP JP1258007A patent/JPH0737394B2/en not_active Expired - Fee Related
- 1989-10-05 CN CN89107651A patent/CN1027575C/en not_active Expired - Fee Related
-
1997
- 1997-01-08 LU LU90004C patent/LU90004I2/en unknown
- 1997-02-26 NL NL970009C patent/NL970009I2/en unknown
-
1998
- 1998-05-05 NO NO1998014C patent/NO1998014I1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU90004I2 (en) | Levovist | |
Walsh et al. | Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia | |
US4596557A (en) | Air eliminator for intravenous tube | |
CA2211100A1 (en) | Diagnostic imaging contrast agents with extended blood retention | |
IL97411A (en) | Pharmaceutical formulations comprising hapten-modified diagnostic or therapeutic agents | |
FI884051A (en) | Method for preparing stabilized human protein preparations | |
MA21264A1 (en) | COMPOSITION FOR ADMINISTERING MEDICAMENT IN THE FORM OF CELLS, POWDER OR LIQUID. | |
Kobayashi et al. | Influence of contrast ultrasonography with perflutren lipid microspheres on microvessel injury | |
Lang et al. | Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility | |
Marriott | Dependence on antiparkinsonian drugs. | |
Bertuglia | Increase in capillary perfusion following low-intensity ultrasound and microbubbles during postischemic reperfusion | |
Ree et al. | Laboratory diagnosis of malaria. | |
Chaudhuri et al. | Uptake of 87mSr by liver metastasis from carcinoma of colon | |
Roth et al. | Lipemia-Induced Acceleration of Intravascular Clotting. | |
JOHANSSON et al. | 6‐Hydroxydopamine and the blood‐brain barrier in adult conscious rats | |
Valli et al. | Pathology of T. congolense in calves | |
ALLARD et al. | Discordant uptake of technetium-99m DISIDA and technetium-99m sulfur colloid in an amebic abscess | |
Sutton | ACUTE POSTOPERATIVE NECROSIS OF THE LIVER: AN EXPERIMENTAL STUDY | |
JPH035401A (en) | Immobilization of specimen of organism | |
RU95117020A (en) | METHOD FOR DIAGNOSIS OF THE ATRIAL DEFECT | |
KR20020052072A (en) | Contrast agent and manufacturing method of same | |
Amer et al. | Rompun@ in Goats with Special Reference to its Effect on the Cerebrospinal Fluid (C. SF) | |
ENEMAS | be taught is diminishing, partly as increasing | |
Padron et al. | Incorporation Studies of Iodine131 Labeled Chemically Treated Bovine Plasma |